Ignite Creation Date:
2024-05-05 @ 10:00 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00004223
Status:
COMPLETED
Last Update Posted:
2023-06-18
First Post:
2000-01-28
Brief Title:
Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer
Sponsor:
Eastern Cooperative Oncology Group
Organization:
Eastern Cooperative Oncology Group
Organization Data
Organization:
Eastern Cooperative Oncology Group
Class:
NETWORK
Study ID:
CDR0000067464
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Eastern Cooperative Oncology Group
Lead Sponsor Class:
NETWORK
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Group Chair
Old Organization:
Eastern Cooperative Oncology Group
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |